相关实验视频

Updated: Jul 17, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

主要护理临床医生参与实施一种机器学习算法,用于针对性查家族性高胆固醇血症

Kain Kim¹, Samir C Faruque², David Kulp¹

¹Emory School of Medicine, Atlanta GA 30306, USA.

American journal of preventive cardiology

|August 23, 2024

概括

初级保健临床医生在教育计划后,对家族高胆固醇血症 (FH) 管理的知识有所提高. 然而,他们仍然将FH护理推迟到专家,表明需要进一步的干预策略.

科学领域:

心脏病学心脏病学
医学教育医学教育
公共卫生公共卫生

背景情况:

家族性高胆固醇血症 (FH) 是一种导致高胆固醇和心血管风险增加的遗传疾病.
FH的诊断和治疗显著不足,特别是在初级保健机构.
赋予初级保健临床医生 (PCC) 的权力对于改善FH诊断和管理至关重要.

研究的目的:

评估一项多方面的教育干预,旨在增强PCC关于FH管理的知识,态度和行为.
评估电子病历 (EMR) 决策支持工具和有针对性的宣传在改善FH护理方面的有效性.
授权PCC在初级保健机构内有效诊断和管理FH.

主要方法:

为PCCs制定了一项全面的教育计划,并从2022年7月到2024年3月为PCCs进行了试点.
干预组件包括EMR临床决策支持工具,交互式教育网站,虚拟指导会议和直接推广.
临床医生在基线和随访期间进行了调查,以评估有关FH管理的知识和态度的变化.

主要成果:

70个PCC参与了调查,其中55个完成了基线调查,23个完成了后续调查.
客观知识分数显著提高,受访者正确回答了65%的干预后问题,而基线时只有40%.
尽管承认它们在早期检测中的作用,但100%的直接接触的PCC将FH检查推迟到心脏病学家.

结论:

教育干预可以提高PCC对FH管理的知识.
基于系统的方法,包括EMR决策支持和跨学科合作,对于解决FH至关重要.
需要进一步的战略来克服阻碍PCC独立管理FH的障碍.

关键词:

电子健康记录电子健康记录家庭性高胆固醇血症是什么?机器学习算法机器学习算法

更多相关视频

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

相关概念视频

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...